31788260|t|The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic review.
31788260|a|Clozapine is considered the golden standard in the treatment of therapy-resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. Current evidence suggests that the sublingual use of atropine seems to be safe and effective and could be considered as a first-line treatment of clozapine-induced sialorrhea.
31788260	22	30	atropine	Chemical	MESH:D001285
31788260	51	60	clozapine	Chemical	MESH:D003024
31788260	69	79	sialorrhea	Disease	MESH:D012798
31788260	102	111	Clozapine	Chemical	MESH:D003024
31788260	184	197	schizophrenia	Disease	MESH:D012559
31788260	259	269	sialorrhea	Disease	MESH:D012798
31788260	324	332	atropine	Chemical	MESH:D001285
31788260	417	426	clozapine	Chemical	MESH:D003024
31788260	435	445	sialorrhea	Disease	MESH:D012798
31788260	Negative_Correlation	MESH:D001285	MESH:D012798
31788260	Positive_Correlation	MESH:D003024	MESH:D012798
31788260	Negative_Correlation	MESH:D001285	MESH:D003024
31788260	Negative_Correlation	MESH:D003024	MESH:D012559

